Congenital chylothorax in Opitz G/BBB syndrome [3]

American Journal of Medical Genetics

Volumn 140 A, Issue 10, 2006, Pages 1119-1121

  Funke, Simone ^a   Kellermayer, Richard ^a,c   Czakó, Márta ^a   So, Joyce ^b   Kosztolányi, György ^a   Ertl, Tibor ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c MTA PTE Clinical Genetics Research Group ^*  (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; OCTREOTIDE;

APGAR SCORE; AUTOPSY; CASE REPORT; CENTRAL NERVOUS SYSTEM MALFORMATION; CESAREAN SECTION; CHROMOSOME DELETION 13; CHROMOSOME DUPLICATION; CHYLOTHORAX; CLEFT LIP; CLEFT PALATE; CLINICAL FEATURE; DRUG EFFICACY; ECHOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE MUTATION; HUMAN; HYPOSPADIAS; LETTER; MALE; MID1 GENE; MULTIPLE MALFORMATION SYNDROME; MUTATIONAL ANALYSIS; NEWBORN; OPITZ SYNDROME; PARENTERAL NUTRITION; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THORACOCENTESIS; THORAX RADIOGRAPHY; X CHROMOSOME LINKAGE;

ABNORMALITIES, MULTIPLE; CHYLOTHORAX; CLEFT LIP; DNA MUTATIONAL ANALYSIS; FATAL OUTCOME; HUMANS; HYPERTELORISM; HYPOSPADIAS; INFANT, NEWBORN; KARYOTYPING; MALE; MICROTUBULE PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 33646240575     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31224     Document Type: Letter

References (20)

1. Clarke SA, Lakhoo K, Sherwood W. 2005. Somatostatin for intractable postoperative chylothorax in a premature infant. Pediatr Surg Int 21:390-391.
2. Cox TC, Allen LR, Cox LL, Hopwood B, Goodwin B, Haan E, Suthers GK. 2000. New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome. Hum Mol Genet 9:2553-2562.
3. De Falco F, Cainarca S, Andolfi G, Ferrentino R. Berti C, Rodriguez Criado G, Rittinger O, Dennis N, Odent S, Rastogi A, Liebelt J, Chitayat D, Winter R, Jawanda H. Ballabio A, Franco B, Meroni G. 2003. X-linked Opitz syndrome: Novel mutations in the MID1 gene and redefinition of the clinical spectaim. Am J Med Genet Part A 120A:222-228.
4. Gaudenz K, Roessler E, Quaderi N, Franco B, Feldman G, Gasser DL, Wittwer B, Montini E, Opitz JM, Ballabio A, Muenke M. 1998. Opitz G/BBB syndrome inXp22: Mutations in the MID1 gene cluster in the carboxy-terminal domain. Am J Hum Genet 63:703-710.
5. Goto M, Kawamata K, Kitano M, Watanabe K, Chiba Y. 2003. Treatment of chylothorax in a premature infant using somatostatin. J Perinatol 23:563-564.
6. Granata A, Savery D, Hazan J, Cheung BM, Lumsden A. Quaderi NA. 2005. Evidence of functional redundancy between MID proteins: Implications for the presentation of Opitz syndrome. Dev Biol 277:417-424.
7. Ho NK, Leong NK, Lim SB. 1989. Chylothorax in Down's syndrome associated with hydrops fetalis. J Singapore Pediatr Soc 31:90-92.
8. Leichtmann LG, Werner A, Bass WT, Smith D, Brothmann AR. 1991. Apparent Opitz BBBG syndrome with a partial duplication of 5p. Am J Med Genet 40:173-176.
9. Maayan-Metzger A, Sack J. Mazkereth R, Vardi A, Kuint J. 2005. Somatostatin treatment of congenital chylothorax may induce transient hypothyreoidism in newborns. Acta Paediatr 94:785-789.
10. Opitz JM, Frias JL, Gutenberger JE, Pellet JR. 1969a. The G syndrome of multiple congenital anomalies. BD:OAS 2:95-101.
11. Opitz JM, Summitt RL, Smith DW. 1969b. The BBB syndrome: Familial telecanthus with associated congenital anomalies. BD:OAS 2:86-94.
12. Robin NH, Feldmann GJ, Aaronson AL, Mitchell HF, Weksberg R, Leonard CP, Burton BK, Josephson KD, Laxova R, Aleck KA, Allanson JE, Guinon-Almeida ML, Martin RA, Leichtmann LG, Price RA, Opitz JM, Muenke M. 1995. Opitz-syndrome is genetically heterogenous, with one locus on Xp22, and a second locus on 22q11.2. Nat Genet 11:459-461.
13. Robin NH, Opitz JM, Muenke M. 1996. Opitz G/BBB syndrome: Clinical comparisons of families linked to Xp22 and 22q, and a review of the literature. Am J Med Genet 62:305-317.
14. Schweiger S, Schneider R. 2003. The MID1/PP2A complex: A key to the pathogenesis of Opitz BBB/G syndrome. BioEssays 25:356-366.
15. So J, Suckow V, Kijas Z, Kalscheuer V, Moser B, Winter J, Baars M, Firth H, Lunt P, Hamel B, Meinecke P, Moraine C, Odent S, Schinzel A, van der SmagtJJ, Devriendt K, Albrecht B, Gillessen-Kaesbach G, van der Burgt I, Petrij F, Faivre L, McGaughran J, McKenzie F, Opitz JM, Cox T, Schweiger S. 2005. Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. Am J Med Genet Part A 132A:1-7.
16. Strehl J, Schepke M. Wardelmann E, Caselmann WH. Sauerbruch T. 2003. Chronic diarrhea in a 43-year-old patient. Internist (Berl) 44:626-630.
17. Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, Ropers HH, Schneider R, Schweiger S. 2002. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet 29:287-294.
18. Urioste M, Arroyo I, Villa A, Lorda-Sanchez I, Barrio R. Lopez-Cuesta MJ, Rueda J. 1995. Distal deletion of chromosome 13 in a child with "Opitz" GBBB syndrome. Am J Med Genet 59:114-122.
19. Van Straaten HLM, Gerards LJ, Krediet TG. 1993. Chylothorax in the neonatal period. Eur J Pediatr 152:2-5.
20. Young S, Dalgleish S, Eccleston A, Akierman A, McMillan D. 2004. Severe congenital chylothorax treated with octreotide. J Perinatol 24:200-202.